.png)
Reveal! Who we are and what we stand for
Setting the standard for protein analysis
Our Story
As of 2025, our company has become part of Biognosys Group, a subdivision of Bruker.
Biognosys Group delivers high-performance, robust solutions across proteomics, metabolomics, and lipidomics — driving innovation at the forefront of multiomics. Building on the combined strengths of PreOmics, Biognosys, and biocrates, Biognosys Group integrates industry-leading consumables, software, instruments, and CRO services to make advanced mass spectrometry workflows seamless, scalable, and accessible to every laboratory. The Biognosys Group maintains a vendor-neutral strategy, ensuring open and flexible collaboration across the scientific community and broad compatibility of its solutions across the major mass spectrometry platforms. Designed for agility, Biognosys Group technologies can operate independently or within a unified ecosystem, supported by flexible business models and a strong commitment to partnership.
How it all began
The founder team of PreOmics® started working on optimized LC-MS proteomic workflows at the Matthias Mann lab in 2010. After establishing an optimized and easier sample preparation process in 2014, Dr. Nils A. Kulak together with Dr. Garwin Pichler set forth to validate their technologies with external laboratories and researchers. With a lot of support of proteomics experts, engineers and industry designers, they made their first product ready-for-market. The PreOmics® team won several awards for their business idea, were supported by various accelerator programs and established their company in the beginning of 2016. They are now located at the IZB in Martinsried just south of Munich.
